Zscaler (ZS) Q3 2026 Earnings: Key Takeaways and Market Reaction
Zscaler (ZS) announced its Q3 2026 earnings on May 26, revealing strong results but mixed guidance that led to a significant market reaction...
Revenue Growth:: Doximity reported a 20% year-over-year increase in total revenue for fiscal year 2025, reaching $570.4 million. This growth is a testament to the increasing adoption of its platform and services by medical professionals.
Profitability:: The company's net income margin increased to 39.1% for fiscal year 2025, compared to 31.0% in the previous year. This indicates improved operational efficiency and cost management.
AI Engagement:: Doximity's AI-powered tools saw a 60% sequential increase in usage during the third quarter, with 1.8 million prompts submitted by physicians. This highlights the growing importance of AI in healthcare and Doximity's leadership in this area.
Client Portal Adoption:: The company’s client portal is now used by more than half of its pharmaceutical brand partners, contributing to commercial traction through real-time ROI analytics.
Why This Matters: These insights highlight Doximity's strong position in the healthcare technology sector. The company's ability to drive revenue growth, improve profitability, and increase user engagement underscores its value to medical professionals and pharmaceutical companies alike. The increasing use of AI tools also points to future opportunities for Doximity to further enhance its platform and offerings.
Doximity's fiscal year 2025 results reflect its continued dominance in the digital healthcare space. The company's platform provides a range of tools and services for medical professionals, including collaboration, medical news, career management, and virtual patient visits.
Doximity's Q4 total revenues reached $138.3 million, a 17% increase year-over-year. Operating cash flow also saw a substantial rise, up 54% to $98.5 million. For the full fiscal year, total revenues were $570.4 million, a 20% increase, with operating cash flow up 48% to $273.3 million.
The company's point-of-care and formulary modules experienced over 100% year-over-year growth, accounting for 20% of pharmaceutical sales. Multi-module integrated programs have also contributed to revenue growth by enabling clients to launch campaigns more efficiently.
Doximity provided guidance for its fiscal first quarter ending June 30, 2025, with revenue projected between $139 million and $140 million and adjusted EBITDA between $71 million and $72 million. For the full fiscal year ending March 31, 2026, revenue is expected to be between $619 million and $631 million, with adjusted EBITDA between $333 million and $345 million.
Despite strong performance, Doximity faces challenges such as macroeconomic uncertainty in the health system segment and potential limitations in new bookings during the fourth quarter, which is typically a lighter quarter for client commitments.
What were Doximity's key financial highlights for fiscal year 2025?
Doximity's total revenue increased by 20% year-over-year to $570.4 million, and operating cash flow rose by 48% to $273.3 million.
How is Doximity leveraging AI?
Doximity's AI-powered tools saw a 60% sequential increase in usage during the third quarter, with 1.8 million prompts submitted by physicians, enhancing platform stickiness and long-term monetization potential.
What is Doximity's outlook for fiscal year 2026?
Doximity projects revenue between $619 million and $631 million and adjusted EBITDA between $333 million and $345 million.
Doximity's strong fiscal year 2025 results highlight its leadership in the digital healthcare space. Key takeaways include:
Robust Growth:: Doximity's revenue and cash flow growth demonstrate its increasing value to medical professionals and pharmaceutical companies.
AI Integration:: The company's successful integration of AI tools is driving user engagement and creating new opportunities for monetization.
Strategic Focus:: Doximity's focus on multi-module integrated programs and client portals is enhancing commercial traction and client satisfaction.
Share this with others who need to stay ahead of this trend!
What do you think about Doximity's growth strategy and its impact on the healthcare industry? Let us know in the comments below!
Share this article with others who need to stay ahead of this trend!
Zscaler (ZS) announced its Q3 2026 earnings on May 26, revealing strong results but mixed guidance that led to a significant market reaction...
As Nvidia prepares to release its Q1 earnings report on May 20, 2026, prediction markets and analysts are buzzing with expectations. This ar...
Texas Instruments (TXN) reported its Q1 2026 earnings, showcasing revenue growth and strong shareholder returns. This article delves into th...
Morgan Stanley (MS) has announced its Q1 2026 earnings, surpassing analyst expectations due to a significant boost in trading revenue. The f...
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer